Non-cirrhotic portal hypertension is a rare group of conditions where increased pressure builds up in the blood vessels that carry blood to the liver, even though the liver itself has not developed cirrhosis, the scarring that typically causes this problem. Understanding this condition is important because it can cause serious complications like internal bleeding, yet the liver often continues to function normally.

Epidemiology

Non-cirrhotic portal hypertension, also known as idiopathic non-cirrhotic portal hypertension or porto-sinusoidal vascular disorder, has a worldwide distribution, but its frequency varies greatly depending on where you live^[1]. The condition is particularly common in Asia, especially in countries like India, Nepal, and Japan^[5][6]. In contrast, it appears less frequently in Western countries, which may be partly explained by differences in living conditions, hygiene standards, and exposure to certain infections^[5].

For many years, doctors believed this condition was extremely rare. However, experts now recognize that its low reported frequency was largely due to poor awareness and a lack of suspicion among healthcare providers^[1]. As medical knowledge has improved and doctors have become more familiar with the condition, more cases are being identified.

The age at which people are diagnosed and the gender distribution also vary by region. In Western populations, the typical age at diagnosis is around 40 years, with men being affected more often than women^[5][6]. In India, the disease tends to appear at a younger age but still affects more men than women. Interestingly, in Japan, women are more commonly affected, and the condition typically appears during the fifth decade of life^[6].

Improvements in living standards and hygiene may explain why the number of new cases has been decreasing in Japan over recent decades^[5]. This suggests that environmental factors and socioeconomic conditions play an important role in who develops this condition. The disease is more common in people from socioeconomically disadvantaged backgrounds^[5].

Causes

The exact cause of non-cirrhotic portal hypertension remains largely unknown^[5]. However, researchers have identified five main categories of conditions that are frequently associated with this disorder^[5][6]. Understanding these associations helps doctors recognize when to suspect the condition, even though the precise mechanisms that lead to increased portal pressure are not fully understood.

The first category involves immunological disorders. These are conditions where the body’s immune system does not work properly or attacks its own tissues. Examples include common variable immunodeficiency, a condition where the body cannot produce enough antibodies to fight infections, as well as connective tissue diseases, Crohn’s disease, and systemic lupus erythematosus^[5][11]. A case example described a young woman with common variable immunodeficiency who presented with severe bleeding from enlarged veins in the esophagus^[3].

The second category includes chronic infections. Worldwide, the most common infection associated with portal hypertension is schistosomiasis, a parasitic infection that affects over 230 million people globally^[9][11]. HIV infection and the medications used to treat it have also been linked to this condition^[5][11].

The third category involves exposure to certain medications or toxins. Drugs like azathioprine, which is used to suppress the immune system, and 6-thioguanine, a medication for certain cancers, have been associated with the development of non-cirrhotic portal hypertension^[5][11]. Exposure to trace metals such as arsenic has also been implicated^[5].

The fourth category is genetic predisposition. Some families show multiple members affected by the condition, suggesting an inherited component. The disease has also been associated with specific genetic syndromes such as Adams-Oliver syndrome and Turner disease^[5].

The fifth category involves prothrombotic conditions, which are disorders that make blood clot more easily than normal. These include inherited blood clotting disorders called thrombophilias, myeloproliferative neoplasms (conditions where the bone marrow makes too many blood cells), and antiphospholipid syndrome (an autoimmune disorder that increases clotting risk)^[5][11].

Risk Factors

Several groups of people are at higher risk of developing non-cirrhotic portal hypertension. People living in areas with poor sanitation and hygiene standards face increased risk, particularly where parasitic infections like schistosomiasis are common^[5]. This explains why the condition is more prevalent in certain parts of Asia and why improvements in living conditions have led to fewer cases in countries like Japan.

Individuals with immune system disorders are at elevated risk. This includes people with autoimmune diseases where the body’s immune system attacks its own tissues, as well as those with immunodeficiency disorders where the immune system is weakened^[5][11]. People with inflammatory bowel diseases like Crohn’s disease also have a higher risk.

Those taking certain medications face increased risk. Long-term use of immunosuppressive drugs like azathioprine, which is commonly prescribed for autoimmune conditions and after organ transplants, has been linked to the development of this condition^[5][11]. Didanosine, an antiretroviral medication used to treat HIV, has also been associated with the disease^[11].

People with inherited or acquired blood clotting disorders are at risk. These conditions cause blood to clot too easily, which can lead to small blood clots forming in the tiny blood vessels within the liver^[5]. This includes people with genetic thrombophilias, those with myeloproliferative disorders affecting blood cell production, and individuals with antiphospholipid syndrome.

Exposure to certain toxins and trace metals, particularly arsenic, increases the risk of developing non-cirrhotic portal hypertension^[5]. People who work in industries where they might be exposed to these substances or those living in areas where drinking water is contaminated with arsenic should be aware of this risk.

Having HIV infection increases risk, both because of the infection itself and because some of the medications used to treat it are associated with the condition^[5][11]. Chronic infections that persist over many years also appear to increase the likelihood of developing portal hypertension without cirrhosis.

Symptoms

Many people with non-cirrhotic portal hypertension do not have any symptoms at all until complications develop^[11]. When symptoms do appear, they are typically related to increased pressure in the blood vessels that carry blood through the digestive system to the liver. This increased pressure causes blood to be diverted into other veins, making them expand and become fragile.

The most common way that non-cirrhotic portal hypertension is discovered is when a patient experiences bleeding from enlarged veins. Approximately 70% of patients present with gastrointestinal hemorrhage, which means bleeding somewhere in the digestive tract^[11][6]. This often involves esophageal varices, which are enlarged, swollen veins in the tube that connects the mouth to the stomach. When these veins rupture, they can cause vomiting blood or passing blood in the stool. This bleeding can be severe and life-threatening, requiring immediate medical attention^[3].

Another common symptom is an enlarged spleen, called splenomegaly^[5][6]. The spleen is an organ on the left side of the abdomen that filters blood. When portal pressure increases, blood backs up into the spleen, causing it to swell. Some patients notice abdominal pain or a feeling of fullness because of the enlarged spleen. Others may experience thrombocytopenia, which means having fewer platelets in the blood, making it harder for blood to clot normally. This happens because the enlarged spleen removes too many blood cells from circulation^[5].

Fluid accumulation in the abdomen, called ascites, can occur in non-cirrhotic portal hypertension, though it is less common than in cirrhosis and tends to develop only when there are precipitating factors^[5][6]. When ascites does develop, patients notice their abdomen becoming swollen and distended, their clothes fitting more tightly, and they may gain weight rapidly from the fluid. In severe cases, the fluid can make breathing difficult and affect appetite.

Some patients develop swelling in their legs and feet, called edema^[9]. This happens when fluid leaks out of blood vessels and accumulates in the tissues. The swelling is usually worse at the end of the day and may improve after resting with the legs elevated.

Although less common than in cirrhosis, some patients with non-cirrhotic portal hypertension can experience hepatic encephalopathy, which is confusion or disorientation caused by toxins that the liver normally removes from the blood^[5][11]. This typically occurs when there is massive shunting of blood away from the liver or when there are other triggering factors.

An important feature that distinguishes non-cirrhotic portal hypertension from cirrhosis is that liver function is usually well preserved. This means that even though patients have serious complications like bleeding from varices or an enlarged spleen, their liver continues to work relatively normally^[11]. The liver’s machinery still functions, but there is an obstruction affecting blood flow through the organ. This is why patients often look healthier and have better overall function compared to people with cirrhosis who have similar complications.

Prevention

Because the exact causes of non-cirrhotic portal hypertension are not fully understood, specific prevention strategies are limited. However, reducing exposure to known risk factors can help lower the likelihood of developing the condition.

Improving sanitation and hygiene is important, particularly in regions where parasitic infections like schistosomiasis are common. Access to clean water, proper waste disposal, and avoiding contact with contaminated water sources can help prevent these infections^[5]. Public health measures that improve living standards have been associated with decreasing rates of the disease in countries like Japan.

For people taking medications known to be associated with non-cirrhotic portal hypertension, regular monitoring by healthcare providers is essential. This is particularly important for those on long-term immunosuppressive therapy with drugs like azathioprine^[5][11]. Doctors may need to adjust medication doses or switch to alternative treatments if signs of liver blood vessel problems develop. However, patients should never stop prescribed medications without consulting their healthcare provider.

People with known blood clotting disorders should work closely with their doctors to manage these conditions appropriately. Proper treatment of thrombophilias and other prothrombotic conditions may help reduce the risk of small blood clots forming in liver blood vessels^[5].

For individuals with HIV infection, proper medical care and monitoring are important. Both the infection itself and some antiretroviral medications have been linked to the development of non-cirrhotic portal hypertension^[5][11]. Regular follow-up with healthcare providers can help detect problems early.

Avoiding exposure to toxins and trace metals, particularly arsenic, is advisable. People living in areas with known water contamination should use filtered or bottled water. Those working in industries with potential exposure to harmful substances should follow workplace safety guidelines and use appropriate protective equipment.

For people with autoimmune disorders or other conditions associated with non-cirrhotic portal hypertension, regular medical follow-up is crucial. While these underlying conditions may not be preventable, early detection of portal hypertension can help doctors intervene before serious complications occur.

Pathophysiology

The way non-cirrhotic portal hypertension develops involves changes to the blood vessels within the liver, but the precise mechanisms remain unclear^[5][6]. Understanding these changes helps explain why this condition causes symptoms even though the liver tissue itself is not severely scarred like in cirrhosis.

The normal flow of blood through the liver follows a specific path. Blood from the digestive organs, spleen, and pancreas travels through the portal vein into the liver. Inside the liver, this blood flows through increasingly smaller vessels and eventually through tiny channels called sinusoids, where the liver filters the blood and processes nutrients. After filtering, the blood leaves the liver through the hepatic veins and returns to the heart.

In non-cirrhotic portal hypertension, the main problem is increased resistance to blood flow, but this resistance occurs before the blood reaches the sinusoids. This is called pre-sinusoidal portal hypertension^[3][8]. The increased resistance happens because of changes in the small branches of the portal vein within the liver. These changes include thickening and narrowing of the blood vessel walls, a condition called phlebosclerosis, and in some cases, complete blockage of small portal vein branches, referred to as obliterative portal venopathy^[3][6].

The liver tissue itself shows a wide range of microscopic changes. These can range from very minor alterations that are barely visible under the microscope to more noticeable changes like dilation of the sinusoids, areas of portal fibrosis (scarring around the portal veins), and nodular regenerative hyperplasia, where the liver cells grow in a nodular pattern^[5][6]. It remains unclear whether these different appearances represent different stages of the same disease process or whether they might actually be different conditions that share similar clinical presentations.

One important aspect of the pathophysiology is that most patients also have increased blood flow through the spleen^[11]. This contributes to the massive enlargement of the spleen that many patients experience. Some evidence suggests that in certain cases, removing the spleen can lead to improvement in the condition, supporting the idea that splenic blood flow plays a significant role in maintaining the portal hypertension.

When doctors measure the pressure in the liver blood vessels using a procedure called hepatic venous pressure gradient measurement, they often find normal or near-normal readings in patients with non-cirrhotic portal hypertension^[3][8]. This happens because the measurement technique evaluates pressure at the sinusoidal level, and in pre-sinusoidal portal hypertension, the increased pressure exists before the blood reaches the sinusoids. This is different from cirrhosis, where the measurement accurately reflects the increased portal pressure because the obstruction is at the sinusoidal level.

The development of portal vein thrombosis, or blood clots in the portal vein, is common in non-cirrhotic portal hypertension. The prevalence ranges from 13% to 46% of patients^[6]. When the portal vein becomes blocked, the body attempts to create new blood vessels to bypass the blockage, forming what doctors call a portal cavernoma. These new vessels are a tangle of small blood vessels that try to maintain blood flow to the liver.

Despite the significant changes in blood vessel structure and blood flow patterns, the actual liver cells and their function remain relatively preserved in most patients. This is why people with non-cirrhotic portal hypertension can have serious complications like bleeding varices but still maintain good liver function. The liver’s ability to process nutrients, make proteins, and perform its other vital functions continues relatively normally because the liver tissue itself is not extensively damaged by scarring as it is in cirrhosis.